4DM3
Crystal structure of human PNMT in complex adohcy, resorcinol and imidazole
Summary for 4DM3
Entry DOI | 10.2210/pdb4dm3/pdb |
Descriptor | Phenylethanolamine N-methyltransferase, S-ADENOSYL-L-HOMOCYSTEINE, RESORCINOL, ... (5 entities in total) |
Functional Keywords | transferase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 64819.15 |
Authors | Nair, P.C.,Malde, A.K.,Mark, A.E. (deposition date: 2012-02-06, release date: 2012-04-25, Last modification date: 2024-11-27) |
Primary citation | Nair, P.C.,Malde, A.K.,Drinkwater, N.,Mark, A.E. Missing fragments: detecting cooperative binding in fragment-based drug design. ACS Med Chem Lett, 3:322-326, 2012 Cited by PubMed Abstract: The aim of fragment-based drug design (FBDD) is to identify molecular fragments that bind to alternate subsites within a given binding pocket leading to cooperative binding when linked. In this study, the binding of fragments to human phenylethanolamine N-methyltransferase is used to illustrate how (a) current protocols may fail to detect fragments that bind cooperatively, (b) theoretical approaches can be used to validate potential hits, and (c) apparent false positives obtained when screening against cocktails of fragments may in fact indicate promising leads. PubMed: 24900472DOI: 10.1021/ml300015u PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4001 Å) |
Structure validation
Download full validation report
